Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Human Tetanus Immunoglobulin

Approval Number

国药准字S10880001

Company成都蓉生药业有限责任公司

Registration Date

February 5, 2020

Drug Information

Generic Name

破伤风人免疫球蛋白

Trade Name

蓉生逸普

Brand Name

蓉生逸普

Dosage Form

注射剂(注射液)

Strength

2.5ml 250IU/瓶(支)

Drug Type

生物制品

Registration Date

February 5, 2020

Company Information

Applicant Company

Company Name成都蓉生药业有限责任公司

Company Address

成都高新区起步园科园南路7号

Manufacturing Company

Company Name成都蓉生药业有限责任公司

Company Address

四川省成都市双流区菁园路280号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy